Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies

BACKGROUND: The 2030 goal for schistosomiasis is elimination as a public health problem (EPHP), with mass drug administration (MDA) of praziquantel to school-age children (SAC) as a central pillar of the strategy. However, due to coronavirus disease 2019, many mass treatment campaigns for schistosom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kura, Klodeta, Ayabina, Diepreye, Toor, Jaspreet, Hollingsworth, T Deirdre, Anderson, Roy M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928593/
https://www.ncbi.nlm.nih.gov/pubmed/33515038
http://dx.doi.org/10.1093/trstmh/traa202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928593/
https://www.ncbi.nlm.nih.gov/pubmed/33515038
http://dx.doi.org/10.1093/trstmh/traa202

Ejemplares similares